U.S. Leisure Stock News

Event context and recent share performance Vertex (VERX) has been drawing investor attention after a period of weaker share performance, with the stock down about 16% over the past month and about 39% over the past 3 months. See our latest analysis for Vertex. Against a backdrop of weak longer term results, including a 1 year total shareholder return of about 67% in decline, the recent 7 day share price return of 3.69% at a share price of $12.09 hints that downside momentum may be easing...

Wondering whether FactSet Research Systems at around US$224.86 is starting to look like value, or if the recent excitement has already been priced in. The stock has moved 16.0% over the last 7 days and 2.2% over the past month, yet year to date it is down 21.1% and the 1 year return sits at a 49.5% decline. These swings have kept attention on what the current share price actually reflects about the business. This is especially the case after a year where longer term returns, such as the 3...

Recent price performance snapshot CME Group (CME) has drawn investor attention after recent trading, with the share price around $296.94 and mixed returns across different periods, including a negative move over the past month and a positive trend over the past 3 months. See our latest analysis for CME Group. For context, CME Group’s 1 month share price return of a 9.04% decline contrasts with a 10.11% share price gain year to date. The 5 year total shareholder return of 79.09% points to...

HCA Healthcare recently announced that the HCA Healthcare Foundation will provide a US$2.00 million grant to Second Harvest Food Bank of Middle Tennessee to support its new Grow for Good campus in Nashville, alongside highlighting a mixed quarterly report with revenue slightly below expectations but earnings per share ahead of forecasts. The combination of continued investment in network expansion and workforce development, together with community-focused initiatives like Grow for Good,...

In March 2026, Synopsys, Inc. announced a multi-billion-dollar private placement of common shares with participation from new investor Elliott Investment Management L.P., and earlier that month Arm revealed a collaboration with Synopsys on the Arm AGI CPU using Synopsys’ full-stack design tools and IP. This combination of fresh capital and deeper alignment with Arm’s Neoverse ecosystem highlights Synopsys’ role in enabling next-generation custom silicon and complex compute systems. Next,...

In March 2026, Synchrony Financial announced a partnership with Figo Pet Insurance that lets pet owners use CareCredit to pay upfront vet bills and receive approved insurance reimbursements directly as credits to their CareCredit accounts. This integration expands CareCredit’s pet insurance reimbursement ecosystem to more than 1.20 billion insured policyholders across Figo, Pets Best, and Pumpkin, simplifying veterinary payments for customers and clinics. Next, we’ll examine how this...

AirSculpt Technologies (AIRS) has wrapped up FY 2025 with Q4 revenue of US$33.4 million and net income of US$1.3 million, translating to basic EPS of US$0.02. Over the trailing twelve months, the company reported revenue of US$151.8 million and a net loss of US$11.7 million, or a basic EPS loss of US$0.19. During FY 2025, quarterly revenue ranged from US$33.4 million to US$44.0 million, while basic EPS moved between a loss of US$0.15 and a small profit of US$0.02. This puts the latest quarter...

In late March 2026, IonQ’s shares weakened as heightened geopolitical tensions in the Middle East, particularly the conflict with Iran, weighed on broader equity markets and dampened risk appetite. At the same time, IonQ’s memorandum of understanding with South Korea’s KISTI to integrate its quantum systems with local high-performance computing highlights the company’s growing role in global quantum infrastructure and workforce development. Against this backdrop, we’ll explore how...

Tarsus Pharmaceuticals (TARS) has drawn fresh attention after dosing the first participant in its Phase 2 Calliope trial of TP-05, an oral candidate aimed at preventing Lyme disease by killing infected ticks. See our latest analysis for Tarsus Pharmaceuticals. The recent TP-05 progress and TP-03 milestone in China come as the share price sits at US$70.22, with a 7 day share price return of 4.9% but a 90 day share price return showing a 14.2% decline. The 1 year total shareholder return of...

If you are wondering whether Legend Biotech's share price reflects its underlying value, this article breaks down what the current market price may be implying about the company. The stock closed at US$19.05, with returns of 8.2% over the last week and 3.3% over the last month. The 1 year return stands at a 42.7% decline and the 3 year return at a 60.5% decline. Recent coverage around Legend Biotech has focused on its position in the biotech space and how investors are reassessing risk and...

Ameresco (NYSE:AMRC) has introduced a dual Co President structure alongside the appointment of a new Chief Operating Officer. The leadership changes mark a major organizational restructure aimed at supporting growth and project execution across the business. Ameresco focuses on energy efficiency, renewable energy projects, and related services, an area that depends heavily on disciplined project management and long term contracts. As the company works across government, commercial, and...

If you are wondering whether Millrose Properties at US$28.51 still offers value after its recent run, this article will help you frame that question clearly. The stock has seen a 3.1% decline over the last 7 days and an 8.0% decline over the last 30 days, while still showing a 17.4% return over the last year and a 4.4% decline year to date. Recent news flow around Millrose Properties has focused on its position within the real estate sector and how sentiment toward property related names has...

If you are wondering whether ONEOK is priced fairly or if the current share price leaves some value on the table, this breakdown will help you frame that question in a structured way. With the stock at US$87.36, recent returns have been mixed, including a 5.2% decline over the last 7 days, a 1.4% return over 30 days, 17.5% year to date, and an 8.1% decline over the past year, set against a 54.9% and 126.6% return over 3 and 5 years respectively. Recent coverage has largely focused on ONEOK's...

Why Bank of New York Mellon Corporation (BK) Is On Investors’ Radar Bank of New York Mellon Corporation (BK) has attracted attention after a solid run, with total return figures over the past year and past 3 years prompting fresh interest in how the stock is currently priced. See our latest analysis for Bank of New York Mellon. With the share price at $120.97 and a 1-day share price return of 1.97%, recent gains add to a steady upward trend. The 1-year total shareholder return of 46.66% and...

Recent performance context for Paychex stock Paychex (PAYX) has seen its share price under pressure recently, with negative returns over the past week, month and past 3 months, and a 39.26% decline over the past year. See our latest analysis for Paychex. At a share price of US$90.91, the stock’s recent slide is consistent with its 18.96% 3 month share price decline and 39.26% 1 year total shareholder return decline. This suggests momentum has been fading as investors reassess growth prospects...

In late March 2026, Royal Gold, Inc. issued 2026 guidance calling for higher gold, silver, and copper sales volumes than 2025, outlined expectations for minor contributions from other metals based on assumed reference prices, and indicated that sales would be slightly weighted toward the second half of the year. The company also repaid US$125 million on its revolving credit facility, published a detailed 2025/2026 Asset Handbook, and introduced a new five-year outlook that together give...

Q2 Holdings (QTWO) has partnered with Stablecore to give banks and credit unions access to stablecoins, tokenized deposits, and other digital asset products through its existing digital banking platform. See our latest analysis for Q2 Holdings. The Stablecore partnership comes as Q2 Holdings' short-term momentum has softened, with a 30-day share price return showing a 5.65% decline and a 90-day share price return showing a 34.31% decline. The three-year total shareholder return of 105.64%...

Badger Meter (NYSE:BMI) expanded its share repurchase authorization by $75 million, signaling a larger capital return program to shareholders. The move comes alongside an analyst upgrade and fresh insider share purchases, pointing to increased confidence from both the board and management. Management also highlighted continued growth in the SmartCover business, which is becoming a more visible contributor within the portfolio. Badger Meter, trading at $154.21, has had mixed share...

In late March 2026, Sterling Infrastructure drew attention after CEO Joseph Cutillo sold about US$22.7 million of shares, sparking questions about insider confidence and governance. This insider activity stands in contrast to previously strong bullish analyst sentiment, highlighting how management actions can challenge even well-supported investment cases. Next, we examine how the CEO’s sizeable insider sale may affect Sterling Infrastructure’s investment narrative and perceived risk...

International Flavors & Fragrances recently announced that Food Standards Australia New Zealand approved a heart health claim for isolated soy protein, allowing foods in Australia and New Zealand delivering 20–25 grams daily to promote benefits for blood cholesterol as part of a balanced diet. This regulatory milestone expands the scope for IFF’s SOLAE SUPRO soy protein portfolio in plant-based and functional foods, giving brands new ways to link clinically supported heart health benefits...

If you are wondering whether Atlassian's current share price reflects its true worth, the recent performance gives a lot to think about. The stock last closed at US$69.37, with a 4.4% gain over the past 7 days, a 6.0% decline over 30 days, and year to date and 1 year returns of 55.2% and 69.0% declines respectively, alongside a 55.8% decline over 3 years and a 68.1% decline over 5 years. These swings have put valuation in sharper focus for many investors, especially those comparing today's...

Investors may be considering whether Dominion Energy is priced fairly at its recent US$62.05 close, or if the market is missing something about this utility giant's value. The stock has delivered a 2.3% return over the last 7 days and 4.7% year to date, with a 15.5% return over 1 year and a 25.3% return over 3 years. However, the past 30 days show a 1.6% decline and the 5 year return sits at 1.6%. Recent coverage around Dominion Energy has focused on its role as a large US utility and how...

KORE Group Holdings (KORE) reported Q3 FY 2025 revenue of US$68.7 million with a basic EPS loss of US$0.64, alongside trailing twelve month revenue of US$285.4 million and a TTM EPS loss of US$3.57, underscoring that the business is still operating in loss-making territory. Over recent quarters the company has seen revenue hold in a fairly tight band around the US$68 million to US$73 million range, while quarterly EPS losses have moved between roughly US$0.64 and US$1.31. The focus for...

Context for Trinity Industries after recent price moves Trinity Industries (TRN) has seen mixed share performance recently, with a 2.6% move over the past day, a 4.3% gain over the past week, and a 4.6% decline over the past month, drawing fresh attention to its rail-focused business. See our latest analysis for Trinity Industries. Against this backdrop, Trinity Industries’ recent 1 day and 7 day share price gains sit alongside a 24.9% 90 day share price return and a 1 year total shareholder...